Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$22.2M
-77.3% from 2023
Prescriptions
1,939
$11,448.37 per claim
Patients
409
420 prescribers
Total spending, 2024
$22.2M
$54,274.79 per patient
Medicare prescription drug plans paid $22.2M for Votrient in 2024, for 1,939 prescriptions and refills to 409 patients (down 77.3% from 2023). The average cost per claim was $11,448.37.
Pennsylvania had the highest Medicare cost for Votrient in 2024: $2.0M for 186 claims, followed by California ($2.0M).
Vicki Keedy, hematology-oncology in Nashville, TN, had the highest Medicare cost for Votrient in 2024: 31 claims costing $320K.
Votrient is made by Novartis AG (NVS), listed in the Medicare spending data as Novartis.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Vicki Keedy Nashville, TN | Hematology-Oncology | 31 | Under 11 | $320K |
| Vijayakrishna K Gadi Seattle, WA | Medical Oncology | 24 | Under 11 | $316K |
| Lee P Hartner |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 1,601 | 9,188 | 1,786 | $106.6M |
| 2023 | 1,344 | 7,593 | 1,551 | $97.8M |
| 2024 | 420 | 1,939 | 409 | $22.2M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 20 |
| Under 11 |
| $296K |
| Joseph G Parambil Cleveland, OH | Pulmonary Disease | 24 | Under 11 | $283K |
| Maria A Zarzour Houston, TX | Medical Oncology | 16 | Under 11 | $276K |
| Daniel H Shevrin Evanston, IL | Medical Oncology | 14 | Under 11 | $250K |
| Ross E Kerns Knoxville, TN | Hematology-Oncology | 13 | Under 11 | $233K |
| Udaya G Joseph Louisville, KY | Hematology-Oncology | 13 | Under 11 | $223K |
| Victoria T Rizk Basking Ridge, NJ | Medical Oncology | 17 | Under 11 | $213K |
| Elizabeth R Plimack Philadelphia, PA | Hematopoietic Cell Transplantation and Cellular Therapy | 38 | Under 11 | $211K |
| Kellie West Lafayette, LA | Nurse Practitioner | 12 | Under 11 | $207K |
| Julie A Torres Iowa City, IA | Physician Assistant | 12 | Under 11 | $195K |
| Orimisan S Adekolujo Flint, MI | Hematology-Oncology | 12 | Under 11 | $193K |
| Janai R Carr-Ascher Sacramento, CA | Hematology-Oncology | 11 | Under 11 | $192K |
| Seetal Mewar Lake Worth, FL | Hematology-Oncology | 11 | Under 11 | $188K |
| Sunil Narula Chicago, IL | Hematology-Oncology | 13 | Under 11 | $184K |
| Margaret Von-Mehren Philadelphia, PA | Hematopoietic Cell Transplantation and Cellular Therapy | 14 | Under 11 | $182K |
| Laetitia D Simeral Philadelphia, PA | Nurse Practitioner | 11 | Under 11 | $170K |
| Nassim H Nabbout Wichita, KS | Hematology-Oncology | 11 | Under 11 | $167K |
| Matthew L Ryan Green Bay, WI | Hematology-Oncology | 11 | Under 11 | $166K |
| Pamela R Sinclair Rock Hill, SC | Medical Oncology | 11 | Under 11 | $166K |
| Teresa Lee Philadelphia, PA | Hematology-Oncology | 15 | Under 11 | $164K |
| Anthony E Mega Providence, RI | Hematology-Oncology | 18 | Under 11 | $155K |
| Armen Asik Springfield, MA | Medical Oncology | 11 | Under 11 | $143K |
| Christopher L Nelson Aberdeen, SD | Nurse Practitioner | 11 | Under 11 | $132K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Novartis NVS | 1,939 | $22.2M |